Procter & Gamble Health profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY27Jun 2026FY26Jun 2025FY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
Returns
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
——31.2%33.6%
——21.2%23.0%
——40.6%40.8%
——68.3%68.6%
Margins
27.4%26.7%26.6%26.4%
25.7%25.1%24.2%24.1%
34.8%23.8%22.9%—
35.5%26.2%23.7%25.6%
26.4%19.5%17.5%18.7%
——17.9%15.7%
Additional
25.5%25.5%26.5%27.0%
——206.5%40.9%
——−33.2%19.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,000.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,300 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Returns
Return on Common Equity33.5631.18——
Return on Assets23.0121.21——
Return on Capital Employed40.7640.59——
Return on Invested Capital68.5868.34——
Margins
EBITDA Margin26.3526.5826.6727.38
Operating Margin24.1224.2025.0625.73
Incremental Operating Margin—22.9523.8434.76
Pretax Margin25.5523.7426.2235.50
Net Income Margin18.6617.4619.5426.44
FCF Margin15.7417.94——
Additional
Effective Tax Rate26.9726.4725.4825.53
Dvd Payout Ratio40.87206.48——
Sustainable Growth Rate19.84-33.20——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.